COMPANY

NOWDiagnostics, Inc.

HQ: Springdale, AR source · nowdx.com ↗ · Southeast

Also known as NOWDiagnostics · 7 sources

Location: Springdale, AR · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: COVID-19 SARS-CoV-2 Coronavirus Pregnancy Detection Syphilis Infection Treponema Pallidum Infection HSV-2 Infection Herpes Simplex Virus Infection NOWDx COVID-19 Test Diagnostic Test Diagnostic Test: NOWDx Syphilis Test Diagnostic Test: NOWDx HSV-2 Test

5Trials (company is sponsor)2NIH grants

Raises and deals from press releases

Raise Series B · $22.5M · announced Nov 19, 2024 Company release ↗
Source quote
- Nov 19, 2024 · Company release ↗
  “NOWDiagnostics Secures $22.5 Million in Series B Funding”

Raises announced in these releases: $22.5M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Timeline

Oct 14, 2025 Trial start —: First To Know Pregnancy Test - Clinical Evaluation Protocol source ↗
Nov 19, 2024 Raise Series B · $22.5M source ↗
Mar 1, 2023 Trial start —: NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2 source ↗
Oct 4, 2021 Trial start —: NOWDx Test for the Diagnosis of Syphilis source ↗
Apr 1, 2021 Trial start Not phased (device or behavioral study): NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons source ↗
Sep 1, 2020 Trial start Not phased (device or behavioral study): NOWDx Test for the Detection of Antibodies to COVID-19 source ↗

Clinical trials (lead sponsor) 5

Record	Title	Phase	Status	Start	Primary completion
NCT07304531	First To Know Pregnancy Test - Clinical Evaluation Protocol	Not listed	Completed	Oct 14, 2025	May 7, 2026 (actual)
NCT04690413	NOWDx Test for the Detection of Antibodies to COVID-19	Not phased (device or behavioral study)	Completed	Sep 1, 2020	Dec 31, 2020 (actual)
NCT05063344	NOWDx Test for the Diagnosis of Syphilis	Not listed	Completed	Oct 4, 2021	Oct 17, 2023 (actual)
NCT04294030	NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2	Not listed	Withdrawn	Mar 1, 2023	Oct 31, 2023 (estimated)
NCT04799392	NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons	Not phased (device or behavioral study)	Terminated	Apr 1, 2021	Oct 28, 2021 (actual)

NIH awards 2

Annual award amounts. Total $1.2M.

Aug 1, 2024 NIH award 6R21CA258013-03 FY2022: $218,184 awarded for that fiscal year; activity R21 (OTHER_NIH); PI NAUTIYAL, SHIVANI; recipient as written: NOWDIAGNOSTICS, INC., SPRINGDALE, AR. Device for Preservation of Cell Fre source ↗
2020 NIH contract (government contract; not a grant and not an investment round) 272201800055C-P00002-9999-1 FY2020: $937,500 awarded for that fiscal year; activity N44 (OTHER_NIH); PI HONUG ZHU, KELLIE; recipient as written: NOWDIAGNOSTICS, INC., SPRINGDALE, AR. S source ↗